Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling.
Doepner M, Lee I, Natale CA, Brathwaite R, Venkat S, Kim SH, Wei Y, Vakoc CR, Capell BC, Katzenellenbogen JA, Katzenellenbogen BS, Feigin ME, Ridky TW.
Doepner M, et al. Among authors: natale ca.
Sci Adv. 2022 Sep 2;8(35):eabn4007. doi: 10.1126/sciadv.abn4007. Epub 2022 Sep 2.
Sci Adv. 2022.
PMID: 36054350
Free PMC article.